Xiaofang Yi

No ORCID on file · 25 papers in corpus · active 2015-2026

Study types

  • article 22
  • preprint 3

Condition tags

  • endometriosis 25
  • mesh:D004715 8
  • die_deep_infiltrating 6
  • infertility 4
  • bowel_endometriosis 3
  • dyspareunia 1
  • endometrioma 1
  • adenomyosis 1
  • dysmenorrhea 1
article 2026
·doi:10.1097/rd9.0000000000000171
article 2025
Heliyon ·doi:10.1016/j.heliyon.2024.e41543

Introduction: Pregnancy is a special time during which some benign hormonally-responsive lesions could grow and mimic malignancy on clinical evaluation and imaging. Though decidualization of ovarian endometrioma has been reported, little is…

article 2025
·doi:10.1016/j.isurg.2025.10.001

The integration of artificial intelligence (AI) into minimally invasive surgery (MIS) for endometriosis represents a transformative advancement in clinical practice, with the potential to improve preoperative diagnosis, intraoperative guida…

preprint 2024
·doi:10.2139/ssrn.4974517
article 2024
Cell communication and signaling : CCS ·doi:10.1186/s12964-023-01415-7

BACKGROUND: As a dual-function metabolite, succinate has emerged in cell function and plays a key signaling role in linking mitochondrial function to other cellular functions. Succinate accumulation in the cytoplasm is commonly associated w…

article 2024
Endoscopy ·doi:10.1055/a-2440-6251
article 2024
Cell communication and signaling : CCS ·doi:10.1186/s12964-024-01683-x

OBJECTIVES: Interleukin 33 (IL-33) is a crucial inflammatory factor that functions as an alarm signal in endometriosis (EMs). Epithelial-mesenchymal transition (EMT), a process related to inflammatory signals, intracellular reactive oxygen …

article 2023
European radiology ·doi:10.1007/s00330-023-09795-7

OBJECTIVE: To evaluate MRI features of bowel endometriosis (BE) and verify its clinical significance compared with pathological diagnosis. MATERIALS AND METHODS: Since 2018, patients clinically diagnosed with deep endometriosis (DE) and pla…

article 2023
Frontiers in immunology ·doi:10.3389/fimmu.2023.1133672

Background: Endometriosis (EMs) is a chronic inflammatory condition that is highly heterogeneous. Current clinical staging fails to accurately predict drug responses and prognosis. In this study, we aimed to reveal the heterogeneity of ecto…

preprint 2023
·doi:10.21203/rs.3.rs-3303001/v1

Abstract Background As a dual-function metabolite, succinate has emerged in cell function and plays a key signaling role in linking mitochondrial function to other cellular functions. Succinate accumulation in the cytoplasm is commonly asso…

article 2023
Contemporary clinical trials communications ·doi:10.1016/j.conctc.2023.101179

Background: Endometriosis is a common benign gynecological disorder with high risk of recurrence and adverse impact on fertility-sparing. This study aims to evaluate the effectiveness and safety of SanJieZhenTong Capsules, a traditional Chi…

preprint 2023
·doi:10.2139/ssrn.4428801
article 2022
·doi:10.1016/j.jmig.2022.09.187
article 2022
BMC women's health ·doi:10.1186/s12905-022-01666-5

BACKGROUND: This study aimed to summarize and analyze clinical characteristics and reproductive outcomes in postoperative deep infiltrating endometriosis (DIE). METHODS: This retrospective cohort study included 55 reproductive-aged patients…

article 2021
·doi:10.4103/2096-2924.313687

Abstract Objective: To compare the efficacy of the traditional Chinese medicine SanJieZhenTong (SJZT) capsules versus gonadotropin-releasing hormone analogs (GnRHa) or oral contraceptives (OCs) in the postoperative treatment of moderate-to-…

article 2020
·doi:10.3760/cma.j.cn101441-20190827-00380

As a new high-potency progesterone and the first drug for endometriosis, dienogest has been used in overseas markets for 11 years, accumulating relevant experience in efficacy and safety. This article reviewed the application of dienogest i…

article 2020
Experimental cell research ·doi:10.1016/j.yexcr.2020.111815
article 2019
·doi:10.1016/j.jmig.2019.09.355
article 2019
·doi:10.4103/2096-2924.274543

Objective: To investigate factors that may be associated with the recurrence of deep infiltrating endometriosis (DIE) and DIE-related symptoms. Methods: Starting in September 2014, women with a confirmed diagnosis of DIE based on surgical a…

article 2019
Reproduction (Cambridge, England) ·doi:10.1530/rep-19-0411

Immune cells and cytokines have important roles in the pathogenesis of endometriosis. However, the production and role of cytokines of T helper type 1 (Th1) and Th2 cells in the progress of endometriosis have remained to be fully elucidated…

article 2018
·doi:10.3760/cma.j.issn.2096-2916.2018.09.014

Endometriosis (EMS) is a common disease affecting women of reproductive age. It may cause pelvic pain, infertility and decreased quality of life. Since it is difficult to diagnosis at early onset, the average time delayed from onset of symp…

article 2017
The Journal of international medical research ·doi:10.1177/0300060517728208

Objective This study was performed to identify risk factors for postoperative rectovaginal fistula (PRF) in patients with deep infiltrating endometriosis (DIE). Methods Data were retrospectively obtained from the medical records of 104 pati…

article 2016
·doi:10.1016/j.jmig.2016.08.169
article 2016
·doi:10.1016/j.jmig.2016.08.072
article 2015
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2015.08.151